Correction to: Does evidence from RCTs suggest: SGLT2 inhibitors could not reduce myocardial infarction and stroke?

Du, Lixin; Li, Zhigang; Lan, Peng; Huang, Huayu; Cheng, Wende; Xia, Jun

Du, Lixin; Li, Zhigang; Lan, Peng; Huang, Huayu; Cheng, Wende; Xia, Jun.

Afiliación

Du L; Department of Medical Imaging, Shenzhen Longhua District Central Hospital, Shenzhen, 518110, China.
Li Z; Department of Medical Imaging, Shenzhen Longhua District Central Hospital, Shenzhen, 518110, China.
Lan P; Department of Medical Imaging, Shenzhen Longhua District Central Hospital, Shenzhen, 518110, China.
Huang H; Department of Medical Imaging, Shenzhen Longhua District Central Hospital, Shenzhen, 518110, China.
Cheng W; Department of Pathology, Shenzhen Longhua District Central Hospital, Shenzhen, 518110, China.
Xia J; Department of Radiology, Shenzhen Second People's Hospital, Shenzhen, 518035, China. xiajun@email.szu.edu.cn.

Eur J Clin Pharmacol ; 78(10): 1705, 2022 Oct.

Article en En | MEDLINE | ID: mdl-36109392

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Eur J Clin Pharmacol Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Alemania

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google